The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Menopause and the Metabolic Syndrome<subtitle>The Study of Women's Health Across the Nation</subtitle>
Open accessAbstract
BACKGROUND: Cross-sectional studies suggest that prevalence of the metabolic syndrome (MetS) increases from premenopause to postmenopause in women, independent of age. Little is known about why. We hypothesized that the incidence of the MetS increases with progression through menopause and that this increase is explained by the progressive androgenicity of the hormonal milieu. METHODS: This longitudinal, 9-year study of 949 participants in the Study of Women's Health Across the Nation investigates the natural history of the menopausal transition. Participants of 5 ethnicities at 7 geographic sites were recruited when they were premenopausal or early perimenopausal and were eligible for this study if they (1) reached menopause during the study; (2) had never taken hormone therapy, and (3) did not have diabetes mellitus or the MetS at baseline. The primary outcome was the presence of MetS using National Cholesterol Education Program Adult Treatment Panel III criteria. Secondary outcomes were the components of the MetS. RESULTS: By the final menstrual period, 13.7% of the women had new-onset MetS. Longitudinal analyses, centered at the final menstrual period, were adjusted for age at menopause, ethnicity, study site, marital status, education, body mass index, smoking, and aging. Odds of developing the MetS per year in perimenopause were 1.45 (95% confidence interval, 1.35-1.56); after menopause, 1.24 (95% confidence interval, 1.18-1.30). These odds were significantly different (P < .001). An increase in bioavailable testosterone or a decrease in sex hormone-binding globulin levels increased the odds. CONCLUSIONS: As testosterone progressively dominates the hormonal milieu during the menopausal transition, the prevalence of MetS increases, independent of aging and other important covariates. This may be a pathway by which cardiovascular disease increases during menopause.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L’Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,848
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449 · cited 1×
“Menopausal status has been linked to some components of the MetS, but results are inconsistent.(18) Most cross-sectional studies show that postmenopausal women are more likely then premenopausal women to have higher triglyceride and lower high-density lipoprotein cholesterol (HDL-C) levels independent of age,(18) but…”
ResultMenopause and Risk of Cardiovascular Disease: The Framingham Study
KANNEL, W. B., HJORTLAND, M. C., McNAMARA, P. M., & GORDON, T. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-447 · Cited by 1,395
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Warnick, G. R., & Albers, J. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41577-9 · Cited by 1,250
ANDERSON, D. C. (1974) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1974.tb03298.x · Cited by 1,127
SOWERS, M., CRAWFORD, S. L., STERNFELD, B., MORGANSTEIN, D., GOLD, E. B., GREENDALE, G. A., EVANS, D., NEER, R., MATTHEWS, K., SHERMAN, S., et al. (2000) · Menopause · doi:10.1016/b978-012453790-3/50012-3 · Cited by 507
Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study
Kannel, W. B. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90511-4 · Cited by 458
Burger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6740 · Cited by 439 · cited 1×
“With this reduction, there is a progressive shift toward androgen dominance in the hormonal milieu.(10,11) Although little is known about how this hormonal shift influences CVD risk, available studies suggest a link between androgenicity and CVD risk factors.”
BackgroundReproductive Endocrinology: Physiology, Pathophysiology and Clinical Management.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-484_1 · Cited by 413
Sutton-Tyrrell, K., Wildman, R. P., Matthews, K. A., Chae, C., Lasley, B. L., Brockwell, S., Pasternak, R. C., Lloyd-Jones, D., Sowers, M. F., & Torréns, J. I. (2005) · Circulation · doi:10.1161/01.cir.0000157697.54255.ce · Cited by 402
Ko, G., Chan, J., Cockram, C., & Woo, J. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801043 · Cited by 374
Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Bonadonna, R. C., & Muggeo, M. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1251 · Cited by 332
Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex.
Tejada, C., Strong, J. P., Montenegro, M. R., Restrepo, C. S., & Solberg, L. A. (1968) · PubMed · Cited by 287
Correlates of Circulating Androgens in Mid-Life Women: The Study of Women’s Health Across the Nation
Santoro, N., Torrens, J., Crawford, S., Allsworth, J. E., Finkelstein, J. S., Gold, E. B., Korenman, S., Lasley, W. L., Luborsky, J. L., McConnell, D., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2063 · Cited by 246
Heart Disease Risk Determines Menopausal Age Rather Than the Reverse
Kok, H. S., van Asselt, K. M., van der Schouw, Y. T., van der Tweel, I., Peeters, P. H. M., Wilson, P. W. F., Pearson, P. L., & Grobbee, D. E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.066 · Cited by 244
Lasley, B. L., Santoro, N. F., Randolph, J. F., Gold, E. B., Crawford, S. L., Weiss, G., McConnell, D. S., & Sowers, M. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3760 · Cited by 236
Selecting the Best Linear Mixed Model Under REML
Gurka, M. J. (2006) · The American Statistician · doi:10.1198/000313006x90396 · Cited by 200
Jolly, C., & MAHOUDEAU, J. A. (1984) · PubMed · Cited by 191
Effects of Menopause on Trends of Serum Cholesterol, Blood Pressure, and Body Mass Index
Akahoshi, M., Soda, M., Nakashima, E., Shimaoka, K., Seto, S., & Yano, K. (1996) · Circulation · doi:10.1161/01.cir.94.1.61 · Cited by 175
Longitudinal Study of Risk Factors for Coronary Heart Disease Across the Menopausal Transition
Do, K.-A., Green, A., Guthrie, J. R., Dudley, E. C., Burger, H. G., & Dennerstein, L. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010246 · Cited by 172
Menopausal status and risk factors for cardiovascular disease
Peters, H., Westendorp, I. C. D., Hak, A. E., Grobbee, D. E., Stehouwer, C. D. A., Hofman, A., & Witteman, J. C. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00547.x · Cited by 125
The effect of menopause on blood lipid and lipoprotein levels
Aloysio, D. D., Gambacciani, M., Meschìa, M., Pansini, F. S., Modena, A. B., Bolis, P. F., Massobrio, M., Maiocchi, G., & Peruzzi, E. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00315-9 · Cited by 120
Pugeat, M., Moulin, P., Cousin, P., Fimbel, S., Nicolas, M. H., Crave, J. C., & Lejeune, H. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00102-6 · Cited by 118
Deurenberg‐Yap, M., Yian, T. B., Kai, C. S., Deurenberg, P., & van Staveren, W. A. (1999) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.1999.00091.x · Cited by 118
Endogenous sex hormones: Impact on lipids, lipoproteins, and insulin
Haffner, S. M., & Valdez, R. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80058-8 · Cited by 105
Coronary artery disease - is menopause a risk factor?
Gohlke-Bärwolf, C. (2000) · Basic Research in Cardiology · doi:10.1007/s003950070014 · Cited by 94
Torng, P., Su, T., Sung, F. C., Chien, K., Huang, S., Chow, S., & Lee, Y. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00644-x · Cited by 79
Androgens Are Associated with Hemostatic and Inflammatory Factors among Women at the Mid-Life
Sowers, M. R., Jannausch, M. L., Randolph, J. F., McConnell, D. S., Little, R. J. A., Lasley, B. L., Pasternak, R. C., Sutton-Tyrrell, K., & Matthews, K. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0765 · Cited by 68
Perimenopausal changes in serum lipids and lipoproteins: A 7-year longitudinal study
Fukami, K., Koike, K., Hirota, K., Yoshikawa, H., & Miyake, A. (1995) · Maturitas · doi:10.1016/0378-5122(95)00927-d · Cited by 64
Ainy, E., Mirmiran, P., Zahediasl, S., & Azizi, F. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.07.002 · Cited by 62
Guthrie, J. R., Taffe, J. R., Lehert, P., Burger, H., & Dennerstein, L. (2004) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000094208.15096.62 · Cited by 56
Critique of the evidence from large trials of hormone replacement therapy
Rozenbaum, H. (2004) · International Congress Series · doi:10.1016/j.ics.2004.02.006 · Cited by 4
Cited by
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., Allison, M. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000912 · Cited by 1,219
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Understanding weight gain at menopause
Davis, S. R., Castelo-Branco, C., Chedraui, P., Lumsden, M. A., Nappi, R. E., Shah, D., Villaseca, P., & as the Writing Group of the International Menopause Society for World Menopause Day 2012 (2012) · Climacteric · doi:10.3109/13697137.2012.707385 · Cited by 604
El Khoudary, S. R., Greendale, G., Crawford, S. L., Avis, N. E., Brooks, M. M., Thurston, R. C., Karvonen-Gutierrez, C., Waetjen, L. E., & Matthews, K. (2019) · Menopause · doi:10.1097/gme.0000000000001424 · Cited by 562
Metadata
- Authors
- Janssen, I.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2008-07-28
- Volume
- 168
- Issue
- 14
- Pages
- 1568
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2159678191
- Cited by
- 514
- References
- 38
- FWCI
- 14.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.